Lok Shabha informed, “A structured regulatory regime for AYUSH drugs is considered to be set up”. Shripad Naik, the minister of AYUSH said in written to parliament of India, “Government mulls a structured regulatory regime for AYUSH (Ayurveda, Siddha, Unani and Homoeopathy) drugs. The proposal is to have a vertical structure for AYUSH in the Central Drugs Standard Control Organisation (CDSCO). The time frame has not specified but have taken the steps to initiate the proposal”. READ ALSO: Indian Medical Device Registration Process, Introduction to South East Asian markets.
Currently, the state governments enforce the exclusive provisions for the AYUSH drugs in the Drugs and Cosmetics Act, 1940. READ ALSO: Step by Step process to register your medical devices in India. Under the provisions of the Indian Medicine Central Council Act, 1970, and the Homoeopathy Central Council Act, 1973 the government has established the Central Council of Indian Medicine and Central Council of Homoeopathy for regulating the practice of AYUSH medicine” Naik added. In India there were 281 Ayurveda, 191 Homoeopathy, 44 Unani, 18 Naturopathy and 09 Siddha medicine colleges functions and there is no Central Act and Regulatory Central Council for Yoga and Naturopathy. The government of India has received a total of 92 proposals in 2015 for opening new Ayurveda, Siddha, Unani and Homoeopathy medical colleges (government as well as private) in different parts of the country.
Other News
CDSCO Issues Guidelines on Medical Device License Retention
New Delhi, May 15, 2024 — The Central Drugs Standard Control Organization (CDSCO) has released a circular (F. No. MED-15/35/2024-eOffice) on the retention of medical device licenses and certificates under the Medical Devices Rules, 2017. […]
Read More
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
